A Phase 1, Open-label, Randomized, Single Dose, Crossover Study Evaluating The Pharmacokinetics Of Epoetin Following Administration Of Epoetin Hospira Multiple Dose Vial (Mdv) Product Compared To Epoetin Hospira Single Dose Vial (Sdv) Product As Subcutaneous Injection To Normal Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 25 May 2018
At a glance
- Drugs Epoetin zeta (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Pfizer
- 16 May 2018 Status changed from active, no longer recruiting to completed.
- 16 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 30 Jan 2018 Planned primary completion date changed from 1 May 2018 to 11 May 2018.